LASER ASSISTED THERAPIES AND IMMUNOTHERAPIES FOR ONCOLOGY

GLIOBLASTOMA

MALIGNANT PLEURAL MESOTHELIOMA

ACTINIC KERATOSIS & PAGET DISEASE

PERITONEAL CARCINOMATOSIS

IMMUNOTHERAPY

previous arrow
next arrow
Slider

Meeting to set up the BUBOLight® clinical trial

The meeting to set up the pilot, monocentric, descriptive, feasibility, safety and tolerance study of the BUBOLight® device "took place on September 14 at the Jeanne de Flandre Maternity Unit of the [...]

Visit of OncoThAi by an INSERM delegation chaired by Prof. Gilles BLOCH, Chairman and CEO of INSERM.

On September 3, 2020, OncoThAI had the honor to welcome, an INSERM delegation chaired by Prof. Gilles BLOCH, Chairman and CEO of INSERM.

Publication of French standard NF G20-030: Luminous textiles - Determination of the irradiance and luminance of luminous fabrics

 French standard NF G20-030: Luminous textiles - Determination of the irradiance and luminance of luminous fabrics has just been published. OncoThAI, in particular, Elise THECUA, participated in [...]

All news

logo Onco ThAI

OncoThAI “Laser Assisted Therapies and Immunotherapies for Oncology” is directed by Pr. Serge MORDON

This UMR (INSERM, University of Lille, CHU) is made up of 2 teams: ImmunoPDT and Cancer Immunotherapy led by Pr. Nadira DELHEM and PhysicoPDT led by Dr. Maximilien VERMANDEL.

OncoThAI aims to offer an innovative therapy "Photodynamic Therapy (PDT)" essentially for cancers in therapeutic impasse. Indeed, the use of PDT in oncology has seen an increasing interest in recent years. There are, moreover, significant elements supporting the hypothesis of a PDT promoting the activation of the immune response. This property would be a major asset in oncology considering the revolutionary success of anti-tumor immunotherapies.

Based on this rationale, the activities of the ImmunoPDT team aim to develop fundamental and translational clinical projects in order to characterize the effects of PDT, used alone or in combination with conventional treatments, on the regulation of the immune response.

PhysicoPDT develops the technologies necessary for the implementation of PDT in human clinics. In addition to mathematical modeling of mechanisms (in-silico studies), the team has recognized expertise in treatment planning, simulation, light dosimetry and the design of medical devices. Finally, the team relies on proven competence in the implementation of clinical protocols to assess PDT, in particular, thanks to the very strong involvement of clinicians within OncoThAI.

Main research programs concern

Vidéos

OncoThAI YouTube channel